透過您的圖書館登入
IP:18.117.171.8
  • 期刊
  • OpenAccess

Electronic Cigarettes: Should Health Professionals Oppose use by Their Patients?

並列摘要


Aims: Electronic cigarettes are rapidly becoming the most popular type of tobacco-free nicotine product sold in the UK. The aim of this review was to summarize existing literature on the potential risks and benefits posed by e-cigarettes. Methods: A thorough search of relevant databases was undertaken using the search terms: electronic cigarette/s, e-cigarette/s, e-cig/s, electronic nicotine delivery system/s. Results: Electronic cigarettes contain small amounts of toxic chemicals including tobacco-specific nitrosamines, which are known to be human carcinogens; impurities such as myosamine, anabasine, and beta-nicotyrine, which are considered to be harmful to humans; and diethylene glycol, which can be toxic in high doses. Mouth and throat irritation are the most commonly reported side effects in follow-up studies. However, substitution of electronic cigarettes in the homes of parents who currently smoke improves indoor air quality and should be associated with a fall in the risk of sudden infant death syndrome, respiratory illness and ear disease. Conclusion: Electronic cigarettes need standards that reduce product variation and licensing as a medicinal product to provide validated external quality assurance of ingredients and potential contaminants. However, based on their risks and benefits to others, and leaving aside the issues of their use as an aid to smoking cessation, there may be a case for their short-term use where patients have failed to give up smoking using other smoking cessation techniques to reduce exposure of others to second hand smoke.

延伸閱讀